Literature DB >> 11312107

Interactions between endothelial cells and HIV-1.

F Bussolino1, S Mitola, G Serini, G Barillari, B Ensoli.   

Abstract

Endothelial cells (EC) participate in inflammatory and immune reactions by producing and responding to soluble mediators. Human immunodeficiency virus (HIV)-1 profoundly alters the features of EC. In some anatomical districts, they are infected by the virus and may represent a relevant reservoir. During lymphomononuclear cell diapedesis, EC activate virus replication in crossing cells. Direct or indirect damage of EC is particularly relevant in central nervous system, where blood-brain barrier perturbation is pivotal in neuronal degeneration. The observed alterations of EC adhesive properties contribute in altered leukocyte traffic from blood to lymphoid organs and tissues and play a role in the onset of immune surveillance alteration. These alterations of EC functions are relevant for the general vasculopathy, which marks the acquired immunodeficiency syndrome, and in particular are instrumental in the pathogenesis of Kaposi's sarcoma. Here we discuss the biological and molecular activation of EC in HIV-1 infection that represents the basis to understand the pathogenesis of HIV-1 associated vascular diseases.

Entities:  

Mesh:

Year:  2001        PMID: 11312107     DOI: 10.1016/s1357-2725(01)00024-3

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  19 in total

1.  Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins.

Authors:  Li Song; Joel S Pachter
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

Review 2.  Biomarkers and HIV-associated cardiovascular disease.

Authors:  Jason V Baker; Daniel Duprez
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

3.  A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults.

Authors:  Lance T Vernon; Denise C Babineau; Catherine A Demko; Michael M Lederman; Xuelei Wang; Zahra Toossi; Aaron Weinberg; Benigno Rodriguez
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-09       Impact factor: 2.205

4.  ["HAART-attack" in young female HIV-patient].

Authors:  U Pittl; D I Keller; C A Kaiser; M Battegay; M E Pfisterer; A Linka
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

5.  Fibroblast growth factor-2 increases the renal recruitment and attachment of HIV-infected mononuclear cells to renal tubular epithelial cells.

Authors:  Pingtao Tang; Marina Jerebtsova; Ronald Przygodzki; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

6.  Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Authors:  Sulay H Patel; Omnia A Ismaiel; William R Mylott; Moucun Yuan; Kurt F Hauser; MaryPeace McRae
Journal:  Anal Chim Acta       Date:  2019-01-18       Impact factor: 6.558

7.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

Authors:  Francesca Caccuri; Cinzia Giagulli; Antonella Bugatti; Anna Benetti; Giulio Alessandri; Domenico Ribatti; Stefania Marsico; Paola Apostoli; Mark A Slevin; Marco Rusnati; Carlos A Guzman; Simona Fiorentini; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

Review 8.  The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.

Authors:  Jason V Baker; W Keith Henry; James D Neaton
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

9.  Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

Authors:  Francesca J Torriani; Lauren Komarow; Robert A Parker; Bruno R Cotter; Judith S Currier; Michael P Dubé; Carl J Fichtenbaum; Mariana Gerschenson; Carol K C Mitchell; Robert L Murphy; Kathleen Squires; James H Stein
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

10.  Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.

Authors:  Naveed Ahmed Khan; Francescopaolo Di Cello; Avi Nath; Kwang Sik Kim
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.